Treatment of severe hypocalcaemia due to osteoblastic metastases in a patient with post-thyroidectomy hypoparathyroidism with (153)Sm-EDTMP

Symptomatic hypocalcaemia is an uncommon finding in patients with malignant tumours. We describe a patient with advanced metastatic breast cancer who developed severe hypocalcaemia caused by the combination of osteoblastic metastases and a permanent postoperative hypoparathyroidism. The patient fail...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassi, Eva, Kapsali, Ifigeneia, Kokkinos, Michalis, Gogas, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Case Reports 2017
Materias:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753734/
https://www.ncbi.nlm.nih.gov/pubmed/28512123
http://dx.doi.org/10.1136/bcr-2017-219354
_version_ 1783290320772923392
author Kassi, Eva
Kapsali, Ifigeneia
Kokkinos, Michalis
Gogas, Helen
author_facet Kassi, Eva
Kapsali, Ifigeneia
Kokkinos, Michalis
Gogas, Helen
author_sort Kassi, Eva
collection PubMed
description Symptomatic hypocalcaemia is an uncommon finding in patients with malignant tumours. We describe a patient with advanced metastatic breast cancer who developed severe hypocalcaemia caused by the combination of osteoblastic metastases and a permanent postoperative hypoparathyroidism. The patient failed to be treated with the conventional replacement therapy and was submitted effectively to radionucleotide therapy with (153)Sm.
format Online
Article
Text
id pubmed-5753734
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Case Reports
record_format MEDLINE/PubMed
spelling pubmed-57537342018-02-12 Treatment of severe hypocalcaemia due to osteoblastic metastases in a patient with post-thyroidectomy hypoparathyroidism with (153)Sm-EDTMP Kassi, Eva Kapsali, Ifigeneia Kokkinos, Michalis Gogas, Helen BMJ Case Rep Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions Symptomatic hypocalcaemia is an uncommon finding in patients with malignant tumours. We describe a patient with advanced metastatic breast cancer who developed severe hypocalcaemia caused by the combination of osteoblastic metastases and a permanent postoperative hypoparathyroidism. The patient failed to be treated with the conventional replacement therapy and was submitted effectively to radionucleotide therapy with (153)Sm. BMJ Case Reports 2017-05-16 /pmc/articles/PMC5753734/ /pubmed/28512123 http://dx.doi.org/10.1136/bcr-2017-219354 Text en © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Kassi, Eva
Kapsali, Ifigeneia
Kokkinos, Michalis
Gogas, Helen
Treatment of severe hypocalcaemia due to osteoblastic metastases in a patient with post-thyroidectomy hypoparathyroidism with (153)Sm-EDTMP
title Treatment of severe hypocalcaemia due to osteoblastic metastases in a patient with post-thyroidectomy hypoparathyroidism with (153)Sm-EDTMP
title_full Treatment of severe hypocalcaemia due to osteoblastic metastases in a patient with post-thyroidectomy hypoparathyroidism with (153)Sm-EDTMP
title_fullStr Treatment of severe hypocalcaemia due to osteoblastic metastases in a patient with post-thyroidectomy hypoparathyroidism with (153)Sm-EDTMP
title_full_unstemmed Treatment of severe hypocalcaemia due to osteoblastic metastases in a patient with post-thyroidectomy hypoparathyroidism with (153)Sm-EDTMP
title_short Treatment of severe hypocalcaemia due to osteoblastic metastases in a patient with post-thyroidectomy hypoparathyroidism with (153)Sm-EDTMP
title_sort treatment of severe hypocalcaemia due to osteoblastic metastases in a patient with post-thyroidectomy hypoparathyroidism with (153)sm-edtmp
topic Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753734/
https://www.ncbi.nlm.nih.gov/pubmed/28512123
http://dx.doi.org/10.1136/bcr-2017-219354
work_keys_str_mv AT kassieva treatmentofseverehypocalcaemiaduetoosteoblasticmetastasesinapatientwithpostthyroidectomyhypoparathyroidismwith153smedtmp
AT kapsaliifigeneia treatmentofseverehypocalcaemiaduetoosteoblasticmetastasesinapatientwithpostthyroidectomyhypoparathyroidismwith153smedtmp
AT kokkinosmichalis treatmentofseverehypocalcaemiaduetoosteoblasticmetastasesinapatientwithpostthyroidectomyhypoparathyroidismwith153smedtmp
AT gogashelen treatmentofseverehypocalcaemiaduetoosteoblasticmetastasesinapatientwithpostthyroidectomyhypoparathyroidismwith153smedtmp

Ejemplares similares